Cart
sales@molnova.com
4-Amino-5-imidazolecarboxamide
CAS No. 360-97-4
4-Amino-5-imidazolecarboxamide( Aminoimidazole Carboxamide | Colahepat | Diazol-C | Ba 2756 | Ba-2756 | Ba2756 )
Catalog No. M14239 CAS No. 360-97-4
An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | In Stock |
|
Biological Information
-
Product Name4-Amino-5-imidazolecarboxamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide.
-
DescriptionAn imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsAminoimidazole Carboxamide | Colahepat | Diazol-C | Ba 2756 | Ba-2756 | Ba2756
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number360-97-4
-
Formula Weight126.12
-
Molecular FormulaC4H6N4O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(C1=C(N)NC=N1)N
-
Chemical NameImidazole-4-carboxamide, 5-amino-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pastore S, et al. Rheumatol Int. 2015 Apr;35(4):619-27.
molnova catalog
related products
-
Ninerafaxstat
Ninerafaxstat hifts cellular metabolism from fatty acid oxidation to glucose oxidation.Ninerafaxstat decreases fatty acid oxidation and improve overall mitochondrial respiration.Ninerafaxstat inhibit the growth and proliferation of cancer cells .
-
Tartrazine
Tartrazine is a food additive that belongs to a class of artificial dyes and contains an azo group.
-
Stiripentol
Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.
